GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

24 hedge funds and large institutions have $23.4M invested in Galmed Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
II
1
Ibex Investors
Colorado
$5.35M
2
PAWC
2
P.A.W. Capital
Connecticut
$706K
3
Squarepoint
3
Squarepoint
New York
$85K
4
Morgan Stanley
4
Morgan Stanley
New York
$459K
5
WS
5
Wedbush Securities
California
$46K

Top Sellers

1
VC
1
Vivo Capital
California
$0
2
AIM
2
ARK Investment Management
Florida
$0
3
RJA
3
Raymond James & Associates
Florida
$807K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$121K
5
VF
5
Virtu Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
26
Virtu Financial
New York
– -$71K -83 Closed
LNWWM
27
Laird Norton Wetherby Wealth Management
California
– -$48K -56 Closed
UBS Group
28
UBS Group
Switzerland
– -$3K -4 Closed
1
2